Electrolyte supplement and cardiac glycoside combination

This page covers all Electrolyte supplement and cardiac glycoside combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Na+/K+-ATPase (digoxin); magnesium-dependent ion channels and enzymes (magnesium sulfate).

Targets

Na+/K+-ATPase (digoxin); magnesium-dependent ion channels and enzymes (magnesium sulfate)

Phase 3 pipeline (1)

• Magnesium sulfate and then Digoxin · Sunnybrook Health Sciences Centre · Cardiovascular
  Magnesium sulfate reduces cardiac arrhythmias and electrolyte imbalance, while digoxin increases cardiac contractility and slows atrioventricular conduction.

Patent intelligence

• electrolyte supplement and cardiac glycoside combination patent landscape — aggregated cliff calendar, attackable patents, originator estates